1. Can we really reduce the risk for prostate cancer?

   • Mitchell S. Steiner

   Editorial 14 February 2003 Pages: 1 - 2

2. Evolving strategies for prostate cancer chemoprevention trials

   • Ronald Lieberman

   Topic Paper 01 April 2003 Pages: 3 - 8

3. Tomatoes, lycopene and prostate cancer: a clinician's guide for counseling those at risk for prostate cancer

   • Kamal S. Pohar
   • Michael C. Gong
   • Steven K. Clinton

   Topic Paper 22 March 2003 Pages: 9 - 14

4. High-grade prostatic intraepithelial neoplasia and prostate cancer risk reduction

   • Mitchell S. Steiner

   Topic Paper 21 February 2003 Pages: 15 - 20

   

5. The Selenium and Vitamin E Cancer Prevention Trial

   • Eric A. Klein
   • Scott M. Lippman
   • Charles Coltman

   Topic Paper 08 March 2003 Pages: 21 - 27

   

6. The Prostate Cancer Prevention Trial: design, status, and promise

   • Ian M. Thompson
   • Catherine Tangen
   • Phyllis Goodman

   Topic Paper 14 February 2003 Pages: 28 - 30

7. Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk

   • Mitchell S. Steiner
   • Sharan Raghow

   Topic Paper 14 February 2003 Pages: 31 - 36

8. The non-steroidal antiandrogen, bicalutamide ('Casodex'), may preserve bone mineral density as compared with castration: results of a preliminary study

   • C. J. Tyrrell
   • G. M. Blake
   • I. Melezinek

   Free Paper 22 March 2003 Pages: 37 - 42

   

9. Increased discrimination between benign prostatic hyperplasia and prostate cancer with equimolar total prostate specific antigen measurement

   • R. Onur
   • N. Ilhan
   • N. Ilhan

   Free Paper 26 March 2003 Pages: 43 - 47

   

10. Robotic assisted microsurgical vasal reconstruction in a model system

    • Richard A. Schoor
    • Lawrence Ross
    • Craig Niederberger

    Free Paper 26 April 2003 Pages: 48 - 49